alpha-MSH immunomodulation acts via rel/NF-kappa B in cutaneous and ocular melanocytes and in melanoma cells

Ann N Y Acad Sci. 1999 Oct 20:885:396-9. doi: 10.1111/j.1749-6632.1999.tb08698.x.
No abstract available

MeSH terms

  • Adjuvants, Immunologic*
  • Cell Line
  • Humans
  • Melanocytes / drug effects
  • Melanocytes / metabolism*
  • Melanoma
  • NF-kappa B / metabolism*
  • Proto-Oncogene Proteins c-rel / metabolism*
  • Skin Neoplasms
  • Tumor Cells, Cultured
  • Tumor Necrosis Factor-alpha / antagonists & inhibitors
  • Tumor Necrosis Factor-alpha / pharmacology
  • Uvea / cytology
  • Uveal Neoplasms
  • alpha-MSH / pharmacology*

Substances

  • Adjuvants, Immunologic
  • NF-kappa B
  • Proto-Oncogene Proteins c-rel
  • Tumor Necrosis Factor-alpha
  • alpha-MSH